Adma Biologics reported $50.59M in Operating Expenses for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Operating Expenses Change
Adma Biologics ADMA:US $ 50.59M 11.01M
Agile Therapeutics AGRX:US 17.33M 6.54M
Alnylam Pharmaceuticals ALNY:US $ 359.99M 93.1M
Biocryst Pharmaceuticals BCRX:US $ 99.88M 56.38M
China Cord Blood CO:US 167.48M 14.26M
Dynavax Technologies DVAX:US $ 83.23M 31.12M
Minerva Neurosciences NERV:US $ 7.99M 13.39M
Novavax NVAX:US $ 494.68M 552.49M
Takeda 4502:JP 874.91B 90.1B